Company Filing History:
Years Active: 2008-2019
Title: The Innovative Contributions of Matthew G. Jenks
Introduction
Matthew G. Jenks is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused on developing novel compounds that can aid in the treatment of fertility disorders.
Latest Patents
Among his latest patents are benzamide derivatives that serve as positive allosteric modulators of the follicle-stimulating hormone (FSH) receptor. These novel benzamide derivatives, characterized by specific chemical formulas, have the potential to be employed in treating various fertility disorders. The innovative nature of these compounds highlights Jenks' commitment to advancing medical science.
Career Highlights
Throughout his career, Matthew G. Jenks has worked with prominent companies such as Merck Patent GmbH and Serenex, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Jenks has collaborated with esteemed colleagues, including Henry Yu and Thomas E. Richardson. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of his work.
Conclusion
Matthew G. Jenks exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the development of benzamide derivatives, showcase his dedication to improving fertility treatments. His work continues to inspire future advancements in medical research.